Join Dr. Donna Lin as she presents a compelling case of a 62-year-old woman with hypertension, type 2 diabetes, obesity, and heart failure with preserved ejection fraction (HFpEF)—a complex clinical picture that exemplifies the challenges of cardio-kidney-metabolic (CKM) syndrome.
This case study highlights:
- Strategic use of Angiotensin receptor blockers (ARBs), Mineralocorticoid Receptor Agonists (MRAs), Sodium-Glucose Transport Protein (SGLT)-2 inhibitors, and incretin mimetics in the presence of diabetes
- The importance of rhythm control, weight management, and organ protection in the management of cardio-kidney-metabolic syndrome
This is a must-watch for healthcare professionals seeking to understand the evolving landscape of CKM syndrome and the role of targeted therapies in improving outcomes.